Tg Therapeutics (TGTX) Share-based Compensation Growth (3y) (2014 - 2026)
Tg Therapeutics (TGTX) Share-based Compensation Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -50.27% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Tg Therapeutics | 8.08 Bn | 8.00 Bn | 171.41 Mn | 43.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.86% |
| Dec 31, 2025 | -24.63% |
| Sep 30, 2025 | 82.53% |
| Jun 30, 2025 | 170.74% |
| Mar 31, 2025 | 95.99% |
| Dec 31, 2024 | -35.94% |
| Sep 30, 2024 | -3.30% |
| Jun 30, 2024 | -13.79% |
| Mar 31, 2024 | -14.73% |
| Dec 31, 2023 | 133.73% |
| Sep 30, 2023 | -29.41% |
| Jun 30, 2023 | 22.60% |
| Mar 31, 2023 | -13.67% |
| Dec 31, 2022 | 57.19% |
| Sep 30, 2022 | 49.90% |
| Jun 30, 2022 | -36.71% |
| Mar 31, 2022 | 4.07% |
| Sep 30, 2021 | 336.08% |
| Jun 30, 2021 | 56.37% |
| Mar 31, 2021 | 31.33% |